Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...

Phase 1: Discovery and Preclinical Phases: Identification and testing of potential drug compounds. Duration: 1 to 6 years.

Continuous research has led to new drug developments ... comprehensive global coverage of pipeline multiple sclerosis therapies in various stages of clinical development, major pharmaceutical ...

Marie Rahne, director, and Douglas Yee, MD, interim medical director of the Minnesota Cancer Clinical Trial Network spoke to Becker's about how their organization is broadening the scope of cancer ...